Cue Biopharma (CUE) announced that it is commencing an underwritten public offering of shares of its common stock and accompanying warrants to purchase shares of common stock. All of the securities are being offered by Cue Biopharma. Oppenheimer & Co. is acting as sole book-running manager for the offering. Newbridge Securities is acting as co-manager for the offering.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CUE: